vs
BARRETT BUSINESS SERVICES INC（BBSI）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
BARRETT BUSINESS SERVICES INC的季度营收约是Ultragenyx Pharmaceutical Inc.的1.5倍（$321.1M vs $207.3M），BARRETT BUSINESS SERVICES INC净利率更高（5.1% vs -62.0%，领先67.1%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 5.3%），BARRETT BUSINESS SERVICES INC自由现金流更多（$70.6M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 9.9%）
巴雷特枪械制造公司是一家由澳大利亚控股的美国枪械弹药制造商，总部位于田纳西州克里斯蒂安娜。公司由罗尼·G·巴雷特于1982年创立，最初的业务是研发适配.50 BMG弹药的半自动步枪，该弹药原本为勃朗宁M2重机枪研发设计，公司推出的首款成品枪械即为M82狙击步枪。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
BBSI vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $321.1M | $207.3M |
| 净利润 | $16.4M | $-128.6M |
| 毛利率 | 21.3% | — |
| 营业利润率 | 5.8% | -54.7% |
| 净利率 | 5.1% | -62.0% |
| 营收同比 | 5.3% | 25.9% |
| 净利润同比 | -2.4% | 3.5% |
| 每股收益（稀释后） | $0.63 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $321.1M | $207.3M | ||
| Q3 25 | $318.9M | $159.9M | ||
| Q2 25 | $307.7M | $166.5M | ||
| Q1 25 | $292.6M | $139.3M | ||
| Q4 24 | $304.8M | $164.6M | ||
| Q3 24 | $294.3M | $139.5M | ||
| Q2 24 | $279.7M | $147.0M | ||
| Q1 24 | $265.8M | $108.8M |
| Q4 25 | $16.4M | $-128.6M | ||
| Q3 25 | $20.6M | $-180.4M | ||
| Q2 25 | $18.5M | $-115.0M | ||
| Q1 25 | $-1.0M | $-151.1M | ||
| Q4 24 | $16.8M | $-133.2M | ||
| Q3 24 | $19.6M | $-133.5M | ||
| Q2 24 | $16.7M | $-131.6M | ||
| Q1 24 | $-136.0K | $-170.7M |
| Q4 25 | 21.3% | — | ||
| Q3 25 | 24.1% | — | ||
| Q2 25 | 23.8% | — | ||
| Q1 25 | 14.6% | — | ||
| Q4 24 | 23.4% | — | ||
| Q3 24 | 25.3% | — | ||
| Q2 24 | 24.3% | — | ||
| Q1 24 | 14.9% | — |
| Q4 25 | 5.8% | -54.7% | ||
| Q3 25 | 7.8% | -106.9% | ||
| Q2 25 | 7.5% | -64.8% | ||
| Q1 25 | -1.4% | -102.6% | ||
| Q4 24 | 6.8% | -74.3% | ||
| Q3 24 | 8.0% | -94.6% | ||
| Q2 24 | 7.3% | -79.1% | ||
| Q1 24 | -1.8% | -151.9% |
| Q4 25 | 5.1% | -62.0% | ||
| Q3 25 | 6.5% | -112.8% | ||
| Q2 25 | 6.0% | -69.0% | ||
| Q1 25 | -0.3% | -108.5% | ||
| Q4 24 | 5.5% | -80.9% | ||
| Q3 24 | 6.7% | -95.7% | ||
| Q2 24 | 6.0% | -89.5% | ||
| Q1 24 | -0.1% | -156.8% |
| Q4 25 | $0.63 | $-1.28 | ||
| Q3 25 | $0.79 | $-1.81 | ||
| Q2 25 | $0.70 | $-1.17 | ||
| Q1 25 | $-0.04 | $-1.57 | ||
| Q4 24 | $0.63 | $-1.34 | ||
| Q3 24 | $0.74 | $-1.40 | ||
| Q2 24 | $0.62 | $-1.52 | ||
| Q1 24 | $-0.01 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $157.2M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $241.0M | $-80.0M |
| 总资产 | $779.1M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $157.2M | $421.0M | ||
| Q3 25 | $109.8M | $202.5M | ||
| Q2 25 | $90.4M | $176.3M | ||
| Q1 25 | $99.1M | $127.1M | ||
| Q4 24 | $121.9M | $174.0M | ||
| Q3 24 | $14.4M | $150.6M | ||
| Q2 24 | $40.3M | $480.7M | ||
| Q1 24 | $51.3M | $112.3M |
| Q4 25 | $241.0M | $-80.0M | ||
| Q3 25 | $240.1M | $9.2M | ||
| Q2 25 | $225.8M | $151.3M | ||
| Q1 25 | $213.4M | $144.2M | ||
| Q4 24 | $221.4M | $255.0M | ||
| Q3 24 | $215.4M | $346.8M | ||
| Q2 24 | $199.0M | $432.4M | ||
| Q1 24 | $189.6M | $140.3M |
| Q4 25 | $779.1M | $1.5B | ||
| Q3 25 | $777.9M | $1.2B | ||
| Q2 25 | $713.6M | $1.3B | ||
| Q1 25 | $778.6M | $1.3B | ||
| Q4 24 | $745.5M | $1.5B | ||
| Q3 24 | $725.8M | $1.5B | ||
| Q2 24 | $688.6M | $1.6B | ||
| Q1 24 | $747.8M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $76.1M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $70.6M | $-100.8M |
| 自由现金流率自由现金流/营收 | 22.0% | -48.6% |
| 资本支出强度资本支出/营收 | 1.7% | 0.5% |
| 现金转化率经营现金流/净利润 | 4.64× | — |
| 过去12个月自由现金流最近4个季度 | $47.2M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $76.1M | $-99.8M | ||
| Q3 25 | $38.4M | $-91.4M | ||
| Q2 25 | $-53.8M | $-108.3M | ||
| Q1 25 | $5.2M | $-166.5M | ||
| Q4 24 | $53.4M | $-79.3M | ||
| Q3 24 | $-935.0K | $-67.0M | ||
| Q2 24 | $-51.3M | $-77.0M | ||
| Q1 24 | $9.0M | $-190.7M |
| Q4 25 | $70.6M | $-100.8M | ||
| Q3 25 | $34.1M | $-92.7M | ||
| Q2 25 | $-58.2M | $-110.7M | ||
| Q1 25 | $697.0K | $-167.8M | ||
| Q4 24 | $50.2M | $-79.5M | ||
| Q3 24 | $-4.2M | $-68.6M | ||
| Q2 24 | $-56.3M | $-79.0M | ||
| Q1 24 | $6.2M | $-193.9M |
| Q4 25 | 22.0% | -48.6% | ||
| Q3 25 | 10.7% | -58.0% | ||
| Q2 25 | -18.9% | -66.5% | ||
| Q1 25 | 0.2% | -120.5% | ||
| Q4 24 | 16.5% | -48.3% | ||
| Q3 24 | -1.4% | -49.2% | ||
| Q2 24 | -20.1% | -53.7% | ||
| Q1 24 | 2.3% | -178.2% |
| Q4 25 | 1.7% | 0.5% | ||
| Q3 25 | 1.4% | 0.8% | ||
| Q2 25 | 1.4% | 1.5% | ||
| Q1 25 | 1.5% | 1.0% | ||
| Q4 24 | 1.0% | 0.1% | ||
| Q3 24 | 1.1% | 1.2% | ||
| Q2 24 | 1.8% | 1.4% | ||
| Q1 24 | 1.0% | 3.0% |
| Q4 25 | 4.64× | — | ||
| Q3 25 | 1.86× | — | ||
| Q2 25 | -2.92× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.18× | — | ||
| Q3 24 | -0.05× | — | ||
| Q2 24 | -3.07× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BBSI
| Professional Employer Services | $303.6M | 95% |
| Staffing Services | $17.6M | 5% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
